Abstract:Hydrolysis of cisplatin, the most widely used anticancer drug in the world, is believed to be the key activation step before the drug reaching its intracellular target DNA. To obtain an accurate hydrolysis theory for this important class of square-planar Pt(II) complexes, three typical reactions, i.e., the first and second hydrolyses of cisplatin and the hydrolysis of [Pt(dien)Cl](+) (dien = diethylenetriamine), were studied at the experimental temperature with the solvent effect using mPW1PW91/SDD from a comprehensive methodological study on the Hartree-Fock (HF) ab initio method, electron correlation methods, pure density functional theory (DFT) methods, and hybrid HF-DFT methods with several basis sets. The true five stationary states in the second-order nucleophilic substitution (S(N)2) pathway for the hydrolysis process, namely, reactant (R) --> intermediate 1 (I1) --> TS --> intermediate 2 (I2) --> product (P) were obtained and characterized theoretically for the first time. The most remarkable structural variations and the associated atomic charge variations in the hydrolysis process were found to occur in the equatorial plane of the five-coordinate trigonal-bipyramidal (TBP)-like structures of I1, TS, and I2. The reaction with the TS structure of smaller L-M-E angle and more lengthened M-L and M-E bonds was found to have a smaller Gibbs free energy change and accordingly the better hydrolysis yield. It is found that the sum of the three concentric angles in the TBP's equator is near 360 degrees in I1 and I2 and is almost 360 degrees in TS in each reaction. The associated energy profiles again demonstrated a typical S(N)2 reaction curve. The computed forward and backward reaction enthalpy (Delta H(++)) and reaction entropy (Delta S(++)) in the rate-determining step I1 --> TS --> I2 are in good agreement with the experiments. Natural bonding orbital population analysis shows that the charge-separating extent follows the same order of Delta G in studied reactions. Comparing with the computational results of gas-phase reactions, it can be concluded that the solvent effect should be considered to obtain an accurate hydrolysis picture. The most affected structural parameters after solvation are related to the equatorial plane of the TBP-like geometry. The results provide theoretical guidance on detailed understanding on the mechanism of the hydrolysis of cisplatin, which could be useful in the design of novel Pt-based anticancer agents.

Surrounded by ligands: the reactivity of cisplatin in cell culture medium

Reactions of cisplatin and oxaliplatin with penicillin G: implications for drug inactivation and biological activity

Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes

Clickable Cisplatin Derivatives as Versatile Tools to Probe the DNA Damage Response to Chemotherapy

The Events That Occur when Cisplatin Encounters Cells

Review of the toxicological mechanism of anticancer drug cisplatin

Molecular Mechanisms of Chemoresistance and Cytotoxicity Associated with Platinum Drugs

Cell response of Escherichia coli to cisplatin-induced stress

Cellular processing of platinum anticancer drugs

From Basics of Coordination Chemistry to Understanding Cisplatin-analogue Pt Drugs.

Cisplatin and Oxaliplatin: Our Current Understanding of Their Actions

Acidic solvent improves cisplatin action in in-vitro

From Preassociation to Chelation: A Survey of Cisplatin Interaction with Methionine at Molecular Level by IR Ion Spectroscopy and Computations

New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment

Hydrolysis Theory for Cisplatin and Its Analogues Based on Density Functional Studies.

Cisplatin Ototoxicity and Protection: Clinical and Experimental Studies

Control of the nephrotoxicity of cisplatin by clinically used sulfur-containing compounds

Cisplatin Mouse Models: Treatment, Toxicity and Translatability

Probing the interaction of cisplatin with calmodulin and its effect upon binding to myosin light-chain kinase

Synthesis and antiproliferative activity of cisplatin‐3‐chloropiperidine conjugates